Search Results 951-960 of 21420 for anti-TNF drugs

1. Botulism Antitoxin (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

2. Decongestant And Analgesic Combinations (Oral Route) Before Using - Mayo Clinic

   Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

3. Ceftriaxone (Injection Route) Description and Brand Names - Mayo Clinic

   Ceftriaxone belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this ...

4. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

   Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the ...

5. CAR-T Cell Therapy Program

   Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

6. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   ... TNF] agents) within 4 weeks prior to cycle 1, day ... drugs); replacement therapy ... A stable regimen of highly active anti-retroviral therapy (HAART) ...

7. Chlorthalidone (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Antiphospholipid syndrome - Symptoms & causes - Mayo Clinic

   Learn about causes and treatment of this blood disorder that mainly affects women and may cause blood clots and miscarriages.

9. Dextroamphetamine (Transdermal Route) Description and Brand Names - Mayo Clinic

   Dextroamphetamine transdermal patch is used to treat attention-deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central ...

10. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Subject who received IV anti-infectives within 35 days prior to ...